NCT01475123View on ClinicalTrials.gov

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

March 31, 2026

Conditions
Coronary Artery DiseaseEnd Stage Renal Disease
Interventions
DRUG

Nicorandil

15mg per day

Trial Locations (1)

860-8556

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto

All Listed Sponsors
lead

Kumamoto University

OTHER